Aphria Inc. (APHA) no longer exists as a standalone tradable stock; it completed a business combination with in May 2021. As a result, Aphria was delisted from the TSX and NYSE, and its shares were converted into Tilray shares. To gain exposure to the former Aphria business, investors now buy Tilray Brands, Inc. (TLRY) . Investment Thesis: Tilray Brands (Successor to Aphria)
Investors researching Aphria should be aware of past developments that shaped the current company:
: Aphria shareholders received 0.8381 shares of Tilray for each Aphria share they owned.
: A settlement of CAD $30 million was approved in March 2025 to resolve a class-action lawsuit. The suit alleged misrepresentations regarding acquisitions made back in 2018. Information regarding the Aphria Settlement is available for eligible past shareholders.
Aphria Inc. (APHA) no longer exists as a standalone tradable stock; it completed a business combination with in May 2021. As a result, Aphria was delisted from the TSX and NYSE, and its shares were converted into Tilray shares. To gain exposure to the former Aphria business, investors now buy Tilray Brands, Inc. (TLRY) . Investment Thesis: Tilray Brands (Successor to Aphria)
Investors researching Aphria should be aware of past developments that shaped the current company: buy aphria stock
: Aphria shareholders received 0.8381 shares of Tilray for each Aphria share they owned. Aphria Inc
: A settlement of CAD $30 million was approved in March 2025 to resolve a class-action lawsuit. The suit alleged misrepresentations regarding acquisitions made back in 2018. Information regarding the Aphria Settlement is available for eligible past shareholders. To gain exposure to the former Aphria business,